BULLOCK JIM

AEGEA Medical, Inc. develops technology that utilizes convective water vapor to treat menorrhagia. The firm focuses on the development of its proprietary and innovative water vapor treatment for abnormal uterine bleeding. It has vapor system delivers controlled, low-pressure natural water vapor to the uterine cavity to efficiently ablate the inner lining of the uterus. The company was founded by Paul M. Goeld in 2008 and is headquartered in Redwood City, CA.

Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA.

Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN.

Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC.

EnviCor Enterprises LLC designs and manufactures plastic molders. It offers custom molders for the manufacture of paddle boards, barrels, plastic containers, septic equipment and water tanks. The company was founded by G. Steve Arnold in 2006 and is headquartered in Smithfield, NC.

Transomic Technologies, Inc. engages in the provision of life science research services. It serves pharmaceutical, biotech, and academic researchers. The company was founded in 2011 and is headquartered in Huntsville, AL.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

The Tennessee Society of Certified Public Accountants (TSCPA) is the state professional organization for certified public accountants. The society's membership is comprised of members in industry, government, business, education and public accounting. It acts on behalf of its members and provides support, enabling its members to perform quality professional services while serving the public interest. The company was founded in 1924 and is located in Brentwood, TN.

The Enterprise Center, Inc. is a Chattanooga-based organization that unites people, organizations, and technology to build an advanced and inclusive future for the community. The American company serves as the front door of the innovation district, with the Edney Innovation Center as a welcoming and shared space. The fifth floor of the center is a multi-purpose, free, public event space. The Enterprise Center also partners with schools to provide no-cost home internet to qualifying students through the HCS EdConnect program. The innovation district of Chattanooga, established in 2014, is a quarter-mile radius from downtown's Miller Park, where established businesses and startups cluster with educational and cultural institutions.

Glenveigh Medical LLC develops drugs and devices to prevent the causes of premature births. Its products include Ebb, a tamponade solution for postpartum hemorrhage; Jetty, a solution for episiotomy and vaginal laceration repair; and Beacon, a fetal monitor. The company was founded by C. David Adair in 2004 and is headquartered in Chattanooga, TN.

Calon Cardio-Technology Ltd. develops implantable micro blood pumps for the treatment of chronic heart failure. Its lead product, the MiniVAD, a miniature implantable blood pump, is being developed for implantation directly into the left ventricle of the failing heart to help provide adequate blood supply to the body, alleviate the debilitating symptoms of heart failure and improve quality of life. The company was founded by Marc Clement in 2007 and is headquartered in Swansea, the United Kingdom.

Chattanooga Renaissance Fund (Chattanooga Renaissance Fund) is a venture capital firm founded in 2011 by Roddy Bailey and David A. Belitz. The firm is headquartered in Chattanooga, Tennessee.

NX Prenatal, Inc. is amolecular diagnostics company, which engages in the development of diagnostic assays for adverse pregnancy conditions such as preterm birth. The company was founded by Gail S. Page and Brian D. Brohman and is headquartered in Louisville, KY.

Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC.

Revibe Technologies, Inc. develops and sells anti-distraction wristbands that remind kids and adults to stay on-task through online. The company was founded by Rich Brancaccio in December 2013 and is headquartered in Wake Forest, NC.

Francis Medical, Inc. develops an innovative and patented vapor ablation therapy to treat a variety of endourological cancers, beginning with prostate cancer. The company was founded by Michael F. Hoey and is headquartered in Maple Grove, MN.

Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.

EirSystems, Inc. develops an e-Prescribing portal. It offers P.A.G.R. Prescriptions, advanced platform that will allow physicians and pharmacists to utilize built-in tools that make the prescribing process simpler, safer, and more efficient. The company was founded by Tyler Seaberg and Ryan Seaberg and is headquartered in Chattanooga, TN.

Confirmed Consent LLC is a cloud-based healthcare platform that provides electronic confirmation of medical consent. The American company's platform ensures that there is a clear understanding between the patient and provider regarding the medical procedure to be performed, the risks and benefits associated with the procedure, and any alternative options. The private company provides interactive patient education and comprehensive delivery of procedure details by the provider to streamline the perioperative workflow for patients, providers, and facilities. Confirmed Consent aims to change the view of informed consent by converting the archaic system of obtaining consent to a contemporary process where the interests of both the provider and the patient are best served.

GraphiteRx, Inc. operates as a pharmacy marketplace platform. The company is based in Nashville, TN.

QualityMetric, Inc. LLC is a leading provider of COA solutions and technology-enabled scientific consultancy. The company is based in Johnston, RI, and has subsidiaries in the United States. The company specializes in patient-reported outcome measures and offers a comprehensive suite of scientifically validated PRO surveys, integrated COA technology, and strategic consulting services. QualityMetric helps researchers obtain evidence to make decisions through the use of valid and reliable assessments of functional health and well-being. QualityMetric was founded in 1997, and G. Gus Gardner has been the CEO of the company since 2020.

Part of 501 Ventures LLC, Bio 54 LLC is a company that develops topical anti-coagulant drugs. The company is based in Chapel Hill, NC. The CEO of the company is Margaret Powell.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.